Breast Implants Linked to Rare Cancer Are Recalled Worldwide
Under pressure from the Food and Drug Administration, Allergan will stop selling textured implants. 33 deaths have been tied to this type of implant. (Source: NYT)
Source: NYT - July 24, 2019 Category: American Health Authors: Denise Grady Tags: Allergan Inc Cancer Breasts Implants Non-Hodgkin ' s Lymphoma Recalls and Bans of Products Food and Drug Administration your-feed-healthcare Source Type: news
Researchers unveil experimental compound to block therapeutic target in blood cancer
(UNC Lineberger Comprehensive Cancer Center) UNC Lineberger Comprehensive Cancer Center researchers have discovered a hyperactive cell signal that contributes to tumor growth in primary effusion lymphoma, an aggressive type of non-Hodgkin lymphoma caused by infection with the Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8). They also reported in the PNAS paper that they've developed an experimental therapeutic, UNC3810A, to block the signal and slow tumor growth. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 22, 2019 Category: Cancer & Oncology Source Type: news
Notes from the Field: Conjunctivitis Caused by Toxigenic Corynebacterium ulcerans --- Missouri, 2018
On December 12, 2018, an immunocompromised man with non-Hodgkin ' s lymphoma, aged 73 years, was evaluated by an ophthalmologist for left eyelid redness, swelling, and eye discharge and received a diagnosis of ligneous (pseudomembranous) conjunctivitis. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - July 11, 2019 Category: American Health Tags: Conjunctivitis MMWR Morbidity & Mortality Weekly Report Pseudomonas Source Type: news
Cancer Victim Sues Monsanto, Says It Misrepresented Safety Of Roundup, Glyphosate
SAN FRANCISCO - A California man on June 21 sued Monsanto Co. in California federal court, contending that he has developed non-Hodgkin lymphoma (NHL) as a result of exposure to glyphosate, the active ingredient in the herbicide Roundup, which he alleges Monsanto has misrepresented as a safe product (Saul Cohen v. Monsanto Company, No. 19-3632, N.D. Calif.). (Source: LexisNexis® Mealey's™ Emerging Toxic Torts Legal News)
Source: LexisNexis® Mealey's™ Emerging Toxic Torts Legal News - July 10, 2019 Category: Medical Law Source Type: news
Class-action lawsuit filed in Calgary over breast implants and cancer
Allergan Inc. is facing legal action after a type of breast implants it sold was linked by Health Canada to a higher risk of a rare form of non-Hodgkin's lymphoma. (Source: CBC | Health)
Source: CBC | Health - June 21, 2019 Category: Consumer Health News Tags: News/Canada/Calgary Source Type: news
A bone marrow transplant saved boy, 10, from cancer - then nearly killed him
Danny Feltwell Jr, 10, suffered from non-Hodgkin lymphoma. A bone marrow transplant treated his relapse, but then he got graft-versus-host disease. An experimental treatment has him back to pitching. (Source: the Mail online | Health)
Source: the Mail online | Health - June 12, 2019 Category: Consumer Health News Source Type: news
FDA approves first chemoimmunotherapy regimen for patients with relapsed or refractory diffuse large B-cell lymphoma
Today, the U.S. Food and Drug Administration granted accelerated approval to Polivy (polatuzumab vedotin-piiq), in combination with the chemotherapy bendamustine and a rituximab product (a combination known as "BR"), to treat adult patients with diffuse large B-cell lymphoma (DLBCL) that has progressed or returned after at least two prior therapies. Polivy is a novel antibody-drug conjugate, and DLBCL is the most common type of non-Hodgkin lymphoma. (Source: World Pharma News)
Source: World Pharma News - June 10, 2019 Category: Pharmaceuticals Tags: Featured FDA Regulatory Affairs Source Type: news
Monsanto Roundup lawsuits spread to Australia
A gardener in Australia has sued Bayer over its Monsanto Roundup weedkiller, the first such lawsuit against the German pharmaceutical giant in that country.
Michael Ogalirolo, 54, a self-employed gardener from Melbourne, said he was diagnosed with non-Hodgkin lymphoma, a type of leukemia, after using Monsanto’s Roundup for more than 20 years, Reuters reported.
“We have great sympathy for any individual with cancer, but the extensive body of scie nce on glyphosate-based herbicides over four… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - June 7, 2019 Category: Pharmaceuticals Authors: Greg Edwards Source Type: news
Cancer-stricken mother, 26, survives after doctors warned her organs would soon start shutting down
Varrie Dunlop, 26, of Ringwood, Hampshire, was diagnosed with stage four non-Hodgkin's lymphoma last November after doctors initially dismissed her fatigue as a viral infection. (Source: the Mail online | Health)
Source: the Mail online | Health - June 7, 2019 Category: Consumer Health News Source Type: news
Pennsylvania Couple: Monsanto Liable For Cancer From Glyphosate Exposure
PHILADELPHIA - A husband and wife on May 30 sued Monsanto Co. in federal court in Pennsylvania, contending that the wife developed non-Hodgkin lymphoma (NHL) as a result of exposure to the company's herbicide Roundup, which the plaintiffs say was marketed despite the company's knowledge that it causes cancer (Ruth Yobs, et al. v. Monsanto Co., No. 19-2362, E.D. Pa.). (Source: LexisNexis® Mealey's™ Emerging Toxic Torts Legal News)
Source: LexisNexis® Mealey's™ Emerging Toxic Torts Legal News - June 5, 2019 Category: Medical Law Source Type: news
Walking speed predicts clinical outcomes in older adults with blood cancers
(American Society of Hematology) How slow -- or fast -- older individuals with blood cancers are able to walk four meters (about 13 feet) holds critical information about their overall health and strongly predicts survival and unplanned hospital visits regardless of age, cancer or treatment type, or other factors, according to a new study published today inBlood. The association was strongest in those with non-Hodgkin lymphoma. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 5, 2019 Category: Cancer & Oncology Source Type: news
Lenalidomide + Rituximab Beneficial in Relapsed/Refractory Non-Hodgkin Lymphoma
The MAGNIFY phase IIIb trial looked at the efficacy and safety of lenalidomide combined with rituximab in relapsed/refractory indolent non-Hodgkin lymphoma. (Source: CancerNetwork)
Source: CancerNetwork - June 3, 2019 Category: Cancer & Oncology Authors: Jim Kling Source Type: news
Bayer receives U.S. FDA breakthrough therapy designation for copanlisib for the treatment of marginal zone lymphoma
Bayer announced today that the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy Designation for copanlisib (Aliqopa™) for the treatment of adult patients with relapsed marginal zone lymphoma (MZL) who have received at least two prior therapies. MZL is an indolent form of non-Hodgkin's Lymphoma (iNHL) and accounts for about 10% of all non-Hodgkin's Lymphoma in the U.S. (Source: World Pharma News)
Source: World Pharma News - May 29, 2019 Category: Pharmaceuticals Tags: Featured Bayer Business and Industry Source Type: news
California Couple Get $2 Billion in Roundup Suit
The couple said they used Roundup on their property for more than three decades and were diagnosed with the same type of cancer, non-Hodgkin lymphoma, four years apart. (Source: WebMD Health)
Source: WebMD Health - May 14, 2019 Category: Consumer Health News Source Type: news
$2 Billion Verdict Against Monsanto Is Third to Find Roundup Caused Cancer
A state jury ’ s award for a Northern California couple followed awards in separate cases in March and August, and was the largest by far. (Source: NYT Health)
Source: NYT Health - May 14, 2019 Category: Consumer Health News Authors: PATRICIA COHEN Tags: Defoliants and Herbicides Bayer AG Monsanto Company California Hazardous and Toxic Substances Non-Hodgkin's Lymphoma Decisions and Verdicts Pilliod, Alberta Pilliod, Alva Source Type: news
